![Erythropoietin and its derivatives: from tissue protection to immune regulation | Cell Death & Disease Erythropoietin and its derivatives: from tissue protection to immune regulation | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-020-2276-8/MediaObjects/41419_2020_2276_Fig1_HTML.png)
Erythropoietin and its derivatives: from tissue protection to immune regulation | Cell Death & Disease
![A review on pharmacological use of recombinant human erythropoietin in renal and nonrenal anemia and other potential applications in clinical practice - ScienceDirect A review on pharmacological use of recombinant human erythropoietin in renal and nonrenal anemia and other potential applications in clinical practice - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0976001616000156-gr2.jpg)
A review on pharmacological use of recombinant human erythropoietin in renal and nonrenal anemia and other potential applications in clinical practice - ScienceDirect
Erythropoiesis-stimulating agents for the management of anemia of chronic kidney disease: past advancements and current innovations - Document - Gale Academic OneFile
![Neuroprotection and endocytosis: erythropoietin receptors in insect nervous systems - Miljus - 2017 - Journal of Neurochemistry - Wiley Online Library Neuroprotection and endocytosis: erythropoietin receptors in insect nervous systems - Miljus - 2017 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c6f8ad4c-689d-4166-8dba-7b8c0359beea/jnc13967-fig-0005-m.jpg)
Neuroprotection and endocytosis: erythropoietin receptors in insect nervous systems - Miljus - 2017 - Journal of Neurochemistry - Wiley Online Library
![Frontiers | A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat | Medicine Frontiers | A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat | Medicine](https://www.frontiersin.org/files/Articles/519597/fmed-07-00393-HTML/image_m/fmed-07-00393-g001.jpg)
Frontiers | A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat | Medicine
![IJMS | Free Full-Text | Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: “Can the Promise Be Kept?” | HTML IJMS | Free Full-Text | Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: “Can the Promise Be Kept?” | HTML](https://www.mdpi.com/ijms/ijms-22-12590/article_deploy/html/images/ijms-22-12590-g001.png)
IJMS | Free Full-Text | Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: “Can the Promise Be Kept?” | HTML
![Erythropoietin as candidate for supportive treatment of severe COVID-19 | Molecular Medicine | Full Text Erythropoietin as candidate for supportive treatment of severe COVID-19 | Molecular Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs10020-020-00186-y/MediaObjects/10020_2020_186_Fig1_HTML.png)
Erythropoietin as candidate for supportive treatment of severe COVID-19 | Molecular Medicine | Full Text
![The clinical impact of the physiological effects of erythropoietin and erythropoietin-stimulating agents on the incidence of malignancy, thrombosis and hypertension: Beyond anaemia | Nefrología The clinical impact of the physiological effects of erythropoietin and erythropoietin-stimulating agents on the incidence of malignancy, thrombosis and hypertension: Beyond anaemia | Nefrología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/X2013251409003574:10518078_f1_290.jpg?idApp=UINPBA000064)
The clinical impact of the physiological effects of erythropoietin and erythropoietin-stimulating agents on the incidence of malignancy, thrombosis and hypertension: Beyond anaemia | Nefrología
![Frontiers | The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know? | Physiology Frontiers | The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know? | Physiology](https://www.frontiersin.org/files/Articles/54097/fphys-04-00176-HTML/image_m/fphys-04-00176-g002.jpg)
Frontiers | The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know? | Physiology
![Proposed model showing the mechanism of Fgf-23 actions on erythropoiesis. | Download Scientific Diagram Proposed model showing the mechanism of Fgf-23 actions on erythropoiesis. | Download Scientific Diagram](https://www.researchgate.net/profile/Sangeetha-Vadakke-Madathil/publication/260130739/figure/fig9/AS:601632177917973@1520451697559/Proposed-model-showing-the-mechanism-of-Fgf-23-actions-on-erythropoiesis.png)